Long-term outcomes of endoscopic submucosal dissection for gastric dysplasia and early neoplasia in a United Kingdom Caucasian population

Table 4 Disease recurrence on subsequent follow-ups

Recurrence of lesions after completed ESD procedures over 10 years	Value, n = 101
CR group
Total number of lesions in CR group	35
Number of lesions under follow-up	32
Number of lesions with no residual disease or recurrence at all follow-ups, n (%)	32 (100)
Indeterminate group
Total number of lesions in indeterminate group	29
Number of lesions under follow-up	23
Number of lesions with no residual disease or recurrence, n (%)	11 (47.8)
Residual disease	5
Local recurrence	2
Metachronous	5
Synchronous	0
Number of lesions showing no recurrence at latest follow-up, n (%)	16 (69.6)
Number of lesions showing disease recurrence at latest follow-up (%)	7 (30.4)
Non-CR group
Total number of lesions in non-CR group	34
Number of lesions under follow-up	21
Number of lesions with no residual disease or recurrence, n (%)	14 (66.7)
Residual disease	2
Local recurrence	3
Metachronous	1
Synchronous	1
Number of lesions showing no recurrence at latest follow-up, n (%)	17 (81.0)
Number of lesions showing disease recurrence at latest follow-up, n (%)	4 (19.0)
Not Assessable - total number of lesions with index histology showing no dysplasia or indefinite for dysplasia	3

ESD: Endoscopic submucosal dissection; CR: Curative resection.